Javascript must be enabled to continue!
Assessment and Improvement of Elixhauser Comorbidity Index for Predicting In-hospital Mortality in Heart Transplant Patients
View through CrossRef
Abstract
Background
Heart transplant (HT) has a high in-hospital mortality of around 5%. Risk prediction in-hospital mortality can be informative for transplant candidacy and post-HT prognosis. Elixhauser Comorbidity Index (ECI) is an ICD diagnostic code-based comorbidity measurement tool that can predict in-hospital mortality. While it has been validated in the large in-patient population, the accuracy of the mortality prediction has not been assessed in HT.
Methods
This study assessed the in-hospital mortality risk prediction by ECI as well as demographic variables in HT patients in the National Inpatient Sample (NIS) database. Demographic information was included in the multivariable ECI with demographics (ECID) model to assess in-hospital mortality. Moreover, ECI and age were used to develop a single index adjusted ECI (aECI) for mortality prediction.
Results
Age best predicts (
c
-statistic = 0.673, 95% CI = 0.638-0.709) in-hospital mortality, followed by ECI (
c
-statistic = 0.638, 95% CI = 0.598-0.678), race (
c
-statistic = 0.571, 95% CI = 0.533-0.609). Sex did not have predictive power (
c
-statistic = 0.501, 95% CI = 0.467-0.535) for in-hospital mortality. The predictive power of ECI was improved (
c
-statistic = 0.753, 95% CI = 0.720-0.785) in the ECID model. The single measure aECI had comparable discriminative power (
c
-statistic = 0.763, 95% CI = 0.731-0.794) to ECID in predicting in-hospital mortality.
Conclusion
This study showed that ECI was an effective measure to predict post-HT in-hospital mortality. The improved measure aECI can be easily derived from ECI as a quick reference to assess post-HT in-hospital mortality in both the clinic and health administration.
Title: Assessment and Improvement of Elixhauser Comorbidity Index for Predicting In-hospital Mortality in Heart Transplant Patients
Description:
Abstract
Background
Heart transplant (HT) has a high in-hospital mortality of around 5%.
Risk prediction in-hospital mortality can be informative for transplant candidacy and post-HT prognosis.
Elixhauser Comorbidity Index (ECI) is an ICD diagnostic code-based comorbidity measurement tool that can predict in-hospital mortality.
While it has been validated in the large in-patient population, the accuracy of the mortality prediction has not been assessed in HT.
Methods
This study assessed the in-hospital mortality risk prediction by ECI as well as demographic variables in HT patients in the National Inpatient Sample (NIS) database.
Demographic information was included in the multivariable ECI with demographics (ECID) model to assess in-hospital mortality.
Moreover, ECI and age were used to develop a single index adjusted ECI (aECI) for mortality prediction.
Results
Age best predicts (
c
-statistic = 0.
673, 95% CI = 0.
638-0.
709) in-hospital mortality, followed by ECI (
c
-statistic = 0.
638, 95% CI = 0.
598-0.
678), race (
c
-statistic = 0.
571, 95% CI = 0.
533-0.
609).
Sex did not have predictive power (
c
-statistic = 0.
501, 95% CI = 0.
467-0.
535) for in-hospital mortality.
The predictive power of ECI was improved (
c
-statistic = 0.
753, 95% CI = 0.
720-0.
785) in the ECID model.
The single measure aECI had comparable discriminative power (
c
-statistic = 0.
763, 95% CI = 0.
731-0.
794) to ECID in predicting in-hospital mortality.
Conclusion
This study showed that ECI was an effective measure to predict post-HT in-hospital mortality.
The improved measure aECI can be easily derived from ECI as a quick reference to assess post-HT in-hospital mortality in both the clinic and health administration.
Related Results
The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
Background
Advanced heart failure patients often have comorbidities of prognostic importance. However, whether total pretransplantation comorbidity burden predicts mort...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data
Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data
Objective:
We extend the literature on comorbidity measurement by developing 2 indices, based on the Elixhauser Comorbidity measures, designed to predict 2 freq...
Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Receiving Induction Only and Are Superior to MRD Positive Patients Receiving Induction and
Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Receiving Induction Only and Are Superior to MRD Positive Patients Receiving Induction and
Background:
Data suggests that the presence of measurable residual disease (MRD) at the time of transplant for AML portends a poor prognosis. The timing of MRD asses...
P1796FACTORS PREDICTING SUBCUTANEOUS INSULIN REQUIREMENT AFTER KIDNEY TRANSPLANT
P1796FACTORS PREDICTING SUBCUTANEOUS INSULIN REQUIREMENT AFTER KIDNEY TRANSPLANT
Abstract
Background and Aims
Diabetes is the most common cause for end stage renal disease leading to kidney transplant. Post tr...
Simultaneous Heart-Kidney Transplant—Does Hospital Experience With Heart Transplant or Kidney Transplant Have a Greater Impact on Patient Outcomes?
Simultaneous Heart-Kidney Transplant—Does Hospital Experience With Heart Transplant or Kidney Transplant Have a Greater Impact on Patient Outcomes?
High institutional transplant volume is associated with improved outcomes in isolated heart and kidney transplant. The aim of this study was to assess trends and outcomes of simult...
FC008: Sex Difference in COVID-19 Mortality Risk among Patients on Kidney Function Replacement Therapy
FC008: Sex Difference in COVID-19 Mortality Risk among Patients on Kidney Function Replacement Therapy
Abstract
BACKGROUND AND AIMS
In the general population with COVID-19, male sex is an established risk factor for mortality. A mo...

